Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
ID06070454

Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions

Led by University of Virginia · Updated on 2025-10-20

91

Participants Needed

1

Research Sites

8 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to measure how often perioperative vulvovaginitis occurs in patients with non-cancerous vulvar disease who need surgical removal of affected tissue. It also examines how vulvovaginitis relates to complications like wound cellulitis and incisional breakdown in these patients undergoing surgical procedures such as simple partial vulvectomy or wide local excision. The study uses a vulvovaginal swab to detect common infections including bacterial vaginosis, trichomonas, and candida on the day of surgery. Participants will have a vulvovaginal swab collected preoperatively to test for infections causing vulvovaginitis. Those testing positive for bacterial vaginosis, candida, or trichomonas form the experimental group. The study involves no drug treatments but focuses on diagnostic testing and monitoring outcomes related to wound healing after vulvar excision. The primary evaluation period extends up to 8 weeks following surgery. During the study, participants will be contacted by phone one week after surgery to assess for vulvovaginitis and wound complications. They will also have a physical exam between 4 to 6 weeks postoperatively to check for wound cellulitis or breakdown. Researchers will measure the rates of these infections and complications to understand their relationship. The total study duration per participant includes the surgical visit and follow-up assessments up to 8 weeks after the procedure.

CONDITIONS

Brief Title

Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Must be 18 years of age
  • Has histologically confirmed non-malignant vulvar pathology
  • Is scheduled or planning for wide local excision or simple partial vulvectomy
  • Signed informed consent obtained prior to any protocol specific procedures
Not Eligible

You will not qualify if you...

  • Unable to give informed consent
  • Women who are pregnant or nursing (lactating) women at time of consent
  • Recent antibiotic use within the last 3 weeks or 5.5 times the half-life of the antibiotic (whichever is shorter)
  • History of prior malignancy within the last 3 years that required systemic chemotherapy or radiation
  • Immunosuppressed or compromised
  • Active HIV infection (must have undetectable viral load)
  • Chronic treatment with corticosteroids or other immunosuppressive agents including topical corticosteroids in the pelvis (inhaled corticosteroids allowed)
  • Active uncontrolled severe infections not responding to antibiotics, except acute or chronic pelvic inflammatory disease
  • Uncontrolled diabetes mellitus

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 screening and enrollment visit (in-person)

Diagnostic Evaluation

Duration - Day of surgery

Participants undergo a vulvovaginal swab test to check for common causes of vulvovaginitis before their surgery.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - Day of surgery to 1 week post-surgery

Participants undergo surgical excision of premalignant vulvar lesions and immediate post-operative care.

1 surgery day visit and 1 phone call follow-up at 1 week

Post-operative Follow-up

Duration - 4 to 6 weeks post-surgery

Participants have a physical exam to assess wound healing and complications after surgery.

1 follow-up visit (in-person)

Trial Site Locations

Total: 1 location

1

University of Virginia

Charlottesville, Virginia, United States, 22908

Actively Recruiting

Loading map...

Research Team

A

Amanda Urban

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SCREENING

Number of Arms

1

Similar Trials

A Phase 1/2, First-in-Human, Open-Label Study of STAR0602, a...

Advanced Solid Tumors

Actively Recruiting

32 locations

The Value of Patient-reported Outcome Measure Assessment and...

Vulva Cancer

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here